In summary, our findings revealed that the up-regulation of TMEM16A is correlated with the constitutive activation of the MEK/ERK and AKT signaling pathways in BRAF-mutated malignant melanoma cells, resulting in a poor prognosis for patients with this tumor. The gene discussed is BRAF; the disease is melanoma.